Practice add-on for people on hemodialysis
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This trial is for people with end-stage kidney disease who are already receiving hemodialysis. It tests a “wise practice” program or approach during dialysis to see if it can help patients in some meaningful way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have end-stage kidney disease.
- You are currently receiving hemodialysis (dialysis through a machine).
- You are able to take part in the study while continuing your regular dialysis schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help people on hemodialysis take better care of their health. It focuses on education and support after months of treatment.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
This study is testing whether adding a special blood-filtering treatment (hemoperfusion) to your regular hemodialysis can improve outcomes for people with end-stage kidney disease. It may be a good option if you have been on dialysis for a while and have little to no remaining kidney function.
This trial tests whether a smartphone app can help people on hemodialysis manage their health better. It is for patients who are comfortable using a phone app and have been on dialysis for at least 3 months.
This study tests a hybrid (online and in-person) education program to help people on hemodialysis feel more comfortable, confident, and in control of their own care. It compares the program to standard care to see if it improves your well-being.
This trial tests if doing exercises while on hemodialysis can help people with end-stage kidney disease. It is for patients aged 50-60 who have been on dialysis for at least 3 months.
Hear when a new Haemolyses and Related Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.